Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

NCT00925730 ·Status: COMPLETED ·Phase: PHASE4

Pimecrolimus and Epidermal Barrier Function

NCT01132079 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis

NCT00150059 ·Status: COMPLETED ·Phase: PHASE4

Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis

NCT00351052 ·Status: COMPLETED ·Phase: PHASE3

Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

NCT00121381 ·Status: COMPLETED ·Phase: PHASE4

Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis

NCT00232011 ·Status: COMPLETED ·Phase: PHASE3

5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis

NCT00120523 ·Status: COMPLETED ·Phase: PHASE3

Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis

NCT00367393 ·Status: COMPLETED ·Phase: PHASE4

Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis

NCT00379678 ·Status: COMPLETED

Quality of Life Study in Adults With Facial Eczema

NCT00120302 ·Status: COMPLETED ·Phase: PHASE4

Study Of Single And Ten Day Repeat Atopical Applications Of GW842470X Cream On The Skin Of Patients With Atopic Dermatitis

NCT00356642 ·Status: COMPLETED ·Phase: PHASE1

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

NCT02896101 ·Status: COMPLETED ·Phase: PHASE3

Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old

NCT00510003 ·Status: COMPLETED ·Phase: PHASE4

Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis

NCT00231998 ·Status: COMPLETED ·Phase: PHASE3

Effect of Pimecrolimus Cream on Cathelicidin Levels in Subjects With Eczema

NCT00946478 ·Status: COMPLETED ·Phase: NA

A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis

NCT02103725 ·Status: COMPLETED ·Phase: PHASE1

Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitis

NCT00610142 ·Status: COMPLETED ·Phase: PHASE2

A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy Participants

NCT04135560 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis

NCT03107611 ·Status: COMPLETED ·Phase: PHASE3

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

NCT00568997 ·Status: ACTIVE_NOT_RECRUITING

Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis

NCT01652885 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis

NCT02118766 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Topical Pimecrolimus in the Treatment of Pityriasis Alba

NCT03834935 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Topical Roflumilast in Adults With Atopic Dermatitis

NCT01856764 ·Status: COMPLETED ·Phase: PHASE2

Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life

NCT04900948 ·Status: COMPLETED ·Phase: PHASE4